Lortinib 150 mg Tablet
  1. Home
  2. Pharma Products
  3. RPG Life Sciences Ltd
  4. Lortinib 150 mg Tablet

Lortinib 150 mg Tablet

Lortinib 150 mg Tablet contains erlotinib 150 mg, an oral targeted anticancer medicine. It is used in the treatment of non-small cell lung cancer and pancreatic cancer. The tablet is taken by mouth on an empty stomach according to the prescribed treatment regimen.

BUY NOW

Category

Erlotinib is an epidermal growth factor receptor tyrosine kinase inhibitor that blocks signaling involved in the growth and spread of certain cancer cells. Lortinib 150 mg Tablet is manufactured by RPG Life Sciences Ltd and is available as a 150 mg oral tablet. The product is supplied in a strip of 10 tablets, according to current product listings. It should be stored below 30°C and taken at least 1 hour before or 2 hours after food, as directed by the treating physician.

Technical Specification

Specification Details
Active Ingredient Erlotinib
Strength 150 mg
Dosage Form Tablet
Route of Administration Oral
Pack Size 10 tablets
Manufacturer RPG Life Sciences Ltd

Product Also Known As

Lortinib 150 mg Tablet, Lortinib 150 Tablet, Lortinib 150 mg, Lortinib Erlotinib Tablet, Erlotinib 150 mg Tablet, Erlotinib 150 mg, Erlotinib Tablet